These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Three different faces of TACI mutations. Cekic S; Cicek F; Karali Y; Gorukmez O; Eren E; Kilic SS Scand J Immunol; 2020 Jun; 91(6):e12879. PubMed ID: 32160337 [No Abstract] [Full Text] [Related]
10. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency. Lee JJ; Ozcan E; Rauter I; Geha RS Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):520-6. PubMed ID: 18978466 [TBL] [Abstract][Full Text] [Related]
11. Identification of a novel immunosubversion mechanism mediated by a virologue of the B-lymphocyte receptor TACI. Grant JR; Moise AR; Jefferies WA Clin Vaccine Immunol; 2007 Jul; 14(7):907-17. PubMed ID: 17538121 [TBL] [Abstract][Full Text] [Related]
13. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Castigli E; Wilson S; Garibyan L; Rachid R; Bonilla F; Schneider L; Morra M; Curran J; Geha R Nat Genet; 2007 Apr; 39(4):430-1. PubMed ID: 17392798 [No Abstract] [Full Text] [Related]
14. Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID). Garibyan L; Lobito AA; Siegel RM; Call ME; Wucherpfennig KW; Geha RS J Clin Invest; 2007 Jun; 117(6):1550-7. PubMed ID: 17492055 [TBL] [Abstract][Full Text] [Related]
16. Genetics of common variable immunodeficiency: role of transmembrane activator and calcium modulator and cyclophilin ligand interactor. Sathkumara HD; De Silva NR; Handunnetti S; De Silva AD Int J Immunogenet; 2015 Aug; 42(4):239-53. PubMed ID: 26096648 [TBL] [Abstract][Full Text] [Related]
17. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Pan-Hammarström Q; Salzer U; Du L; Björkander J; Cunningham-Rundles C; Nelson DL; Bacchelli C; Gaspar HB; Offer S; Behrens TW; Grimbacher B; Hammarström L Nat Genet; 2007 Apr; 39(4):429-30. PubMed ID: 17392797 [No Abstract] [Full Text] [Related]
18. Phenotypic and clinical heterogeneity associated with monoallelic TNFRSF13B-A181E mutations in common variable immunodeficiency. Dong X; Hoeltzle MV; Hagan JB; Park MA; Li JT; Abraham RS Hum Immunol; 2010 May; 71(5):505-11. PubMed ID: 20156508 [TBL] [Abstract][Full Text] [Related]
19. Resolving the polygenic aetiology of a late onset combined immune deficiency caused by NFKB1 haploinsufficiency and modified by PIK3R1 and TNFRSF13B variants. Hargreaves CE; Dhalla F; Patel AM; de Oteyza ACG; Bateman E; Miller J; Anzilotti C; Ayers L; Grimbacher B; Patel SY Clin Immunol; 2022 Jan; 234():108910. PubMed ID: 34922003 [TBL] [Abstract][Full Text] [Related]
20. Rare mutations in TNFRSF13B increase the risk of asthma symptoms in Swedish children. Janzi M; Melén E; Kull I; Wickman M; Hammarström L Genes Immun; 2012 Jan; 13(1):59-65. PubMed ID: 21850030 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]